Peripheral gating of mechanosensation by glial diazepam binding inhibitor
Journal of Clinical Investigation · 15.08.2024 · 134 (16)
DOI: 10.1172/jci176227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 18.06.2024. Verfasst von Xinmeng Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology; The Key Laboratory of Neural and Vascular Biology, Ministry of Education; The Key Laboratory of New Drug Pharmacology and…. Hauptthemen laut MEDLINE: Ganglia, Spinal, Neuroglia, Diazepam Binding Inhibitor. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NINDS NIH HHS, Medical Research Council.
Abstract (Originalsprache)
We report that diazepam binding inhibitor (DBI) is a glial messenger mediating crosstalk between satellite glial cells (SGCs) and sensory neurons in the dorsal root ganglion (DRG). DBI is highly expressed in SGCs of mice, rats, and humans, but not in sensory neurons or most other DRG-resident cells. Knockdown of DBI results in a robust mechanical hypersensitivity without major effects on other sensory modalities. In vivo overexpression of DBI in SGCs reduces sensitivity to mechanical stimulation and alleviates mechanical allodynia in neuropathic and inflammatory pain models. We further show that DBI acts as an unconventional agonist and positive allosteric modulator at the neuronal GABA A receptors, particularly strongly affecting those with a high-affinity benzodiazepine binding site. Such receptors are selectively expressed by a subpopulation of mechanosensitive DRG neurons, and these are also more enwrapped with DBI-expressing glia, as compared with other DRG neurons, suggesting a mechanism for a specific effect of DBI on mechanosensation. These findings identified a communication mechanism between peripheral neurons and SGCs. This communication modulates pain signaling and can be targeted therapeutically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology; The Key Laboratory of Neural and Vascular Biology, Ministry of Education; The Key Laboratory of New Drug Pharmacology and Toxicology, Hebei Medical University, Shijiazhuang, Hebei, China.
- Pain Research Center, Department of Anesthesiology, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
- Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom.
- Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom.
Förderung
- Wellcome Trust
- NINDS NIH HHS
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie
- National Natural Science Foundation of China
- Science Fund for Creative Research Groups of Natural Science Foundation of Hebei Province
- NIH-NINDS
Zitieren
APA
Li, X., Prudente, A. S., Prato, V., Guo, X., Hao, H., Jones, F., Figoli, S., Mullen, P., Wang, Y., Tonello, R., Lee, S. H., Shah, S., Maffei, B., Berta, T., Du, X., & Gamper, N. (2024). Peripheral gating of mechanosensation by glial diazepam binding inhibitor. Journal of Clinical Investigation, 134(16). https://doi.org/10.1172/jci176227
Vancouver
Li X, Prudente AS, Prato V, Guo X, Hao H, Jones F, et al. Peripheral gating of mechanosensation by glial diazepam binding inhibitor. Journal of Clinical Investigation. 2024;134(16). doi:10.1172/jci176227
BibTeX
@article{Li2024,
author = {Li, Xinmeng and Prudente, Arthur Silveira and Prato, Vincenzo and Guo, Xianchuan and Hao, Han and Jones, Frederick and Figoli, Sofia and Mullen, Pierce and Wang, Yujin and Tonello, Raquel and Lee, Sang Hoon and Shah, Shihab and Maffei, Benito and Berta, Temugin and Du, Xiaona and Gamper, Nikita},
title = {Peripheral gating of mechanosensation by glial diazepam binding inhibitor},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {16},
doi = {10.1172/jci176227}
}
EUVIMED